• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从社会角度看西班牙某地区医疗保健领域溃疡性结肠炎的成本:一项数据库研究

Costs of ulcerative colitis from a societal perspective in a regional health care area in Spain: A database study.

作者信息

Aldeguer Xavier, Sicras-Mainar Antoni

机构信息

Hospital Universitari Doctor Josep Trueta, Girona, Spain.

Badalona Serveis Assistencials, Badalona, Spain.

出版信息

Gastroenterol Hepatol. 2016 Jan;39(1):9-19. doi: 10.1016/j.gastrohep.2015.04.007. Epub 2015 Jul 23.

DOI:10.1016/j.gastrohep.2015.04.007
PMID:26211705
Abstract

OBJECTIVES

To estimate the management of UC associated costs from the societal perspective in Spain.

METHODS

Observational, longitudinal study with retrospective data collection based on reviews of outpatient health records. Socio-demographic, clinical and sick leave information was gathered. Patients diagnosed of UC between 2002 and 2012, older than 18 years, followed-up by a minimum of 12 months post diagnosis, with at least two clinical and use of resources data recorded, were included.

RESULTS

285 UC patients [51.2% men; 44.5 (SD: 15.6) years old; 88.4% without family history of UC; 39.3% proctitis; 5.6 (2.5) years disease follow-up] participated. More than half (65.6%) were active workers, 75.9% were on sick leave for reasons different from UC [mean 0.66 (0.70) times per year] during (mean) 28.43 (34.45) days. Only 64 patients were on UC-related sick-leaves, lasting (mean) 26.17 (37.43) days. Absenteeism due to medical visits caused loss of 29.55 (21.38) working hours per year. Mean direct and indirect annual cost per UC patient were €1754.10 (95%CI: 1473.37-2034.83) and €399.32 (282.31-422.69), respectively. Absenteeism was estimated at €88.21(32.72-50.06) per patient per year, in which sick-leaves were the main component of indirect costs (88.2%). Age, UC family history, diarrhea at diagnosis, blood and blood-forming organs diseases and psychological disorders were the main predictors of indirect costs.

CONCLUSIONS

UC is a costly disease for the society and the Spanish National Healthcare System. Indirect costs imply a major burden by affecting the most productive years of patients. Further research is needed considering all components of productivity loss, including presenteeism-associated costs.

摘要

目的

从西班牙社会角度估算与溃疡性结肠炎(UC)相关的管理成本。

方法

基于门诊健康记录回顾进行回顾性数据收集的观察性纵向研究。收集社会人口统计学、临床和病假信息。纳入2002年至2012年间诊断为UC、年龄超过18岁、诊断后至少随访12个月且至少记录两次临床和资源使用数据的患者。

结果

285例UC患者参与研究[男性占51.2%;年龄44.5(标准差:15.6)岁;88.4%无UC家族史;39.3%为直肠炎;疾病随访时间为5.6(2.5)年]。超过一半(65.6%)为在职员工,75.9%因UC以外的原因休病假[平均每年0.66(0.70)次],休假时间平均为28.43(34.45)天。只有64例患者因UC休病假,病假时间平均为26.17(37.43)天。因就医缺勤导致每年损失29.55(21.38)个工作小时。每位UC患者每年的直接和间接成本平均分别为1754.10欧元(95%置信区间:1473.37 - 2034.83)和399.32欧元(282.31 - 422.69)。估计每位患者每年的缺勤成本为88.21(32.72 - 50.06)欧元,其中病假是间接成本的主要组成部分(88.2%)。年龄、UC家族史、诊断时的腹泻、血液及造血器官疾病和心理障碍是间接成本的主要预测因素。

结论

UC对社会和西班牙国家医疗保健系统来说是一种成本高昂的疾病。间接成本通过影响患者最具生产力的年份带来了重大负担。需要进一步研究考虑生产力损失的所有组成部分,包括与出勤主义相关的成本。

相似文献

1
Costs of ulcerative colitis from a societal perspective in a regional health care area in Spain: A database study.从社会角度看西班牙某地区医疗保健领域溃疡性结肠炎的成本:一项数据库研究
Gastroenterol Hepatol. 2016 Jan;39(1):9-19. doi: 10.1016/j.gastrohep.2015.04.007. Epub 2015 Jul 23.
2
Direct and indirect healthcare resource utilization and costs associated with ulcerative colitis in a privately-insured employed population in the US.美国私人保险就业人群中与溃疡性结肠炎相关的直接和间接医疗资源利用及成本
J Med Econ. 2015 Jun;18(6):447-56. doi: 10.3111/13696998.2015.1021353. Epub 2015 Mar 27.
3
Indirect costs associated with ulcerative colitis: a systematic literature review of real-world data.与溃疡性结肠炎相关的间接成本:真实世界数据的系统文献回顾。
BMC Gastroenterol. 2019 Nov 9;19(1):179. doi: 10.1186/s12876-019-1095-9.
4
Healthcare use, work loss and total costs in incident and prevalent Crohn's disease and ulcerative colitis: results from a nationwide study in Sweden.在瑞典进行的全国性研究:首发和现患克罗恩病和溃疡性结肠炎的医疗保健利用、工作损失和总费用。
Aliment Pharmacol Ther. 2020 Aug;52(4):655-668. doi: 10.1111/apt.15889. Epub 2020 Jul 3.
5
The direct and indirect cost burden of Crohn's disease and ulcerative colitis.克罗恩病和溃疡性结肠炎的直接及间接成本负担
J Occup Environ Med. 2008 Nov;50(11):1261-72. doi: 10.1097/JOM.0b013e318181b8ca.
6
Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNFα therapy: results from the COIN study.炎症性肠病的医疗费用已经从住院和手术转向抗 TNFα 治疗:来自 COIN 研究的结果。
Gut. 2014 Jan;63(1):72-9. doi: 10.1136/gutjnl-2012-303376. Epub 2012 Nov 7.
7
Societal costs attributable to Crohn's disease and ulcerative colitis within the first 5 years after diagnosis: a Danish nationwide cost-of-illness study 2002-2016.诊断后前5年内克罗恩病和溃疡性结肠炎所致的社会成本:一项2002 - 2016年丹麦全国疾病成本研究
Scand J Gastroenterol. 2020 Jan;55(1):41-46. doi: 10.1080/00365521.2019.1707276. Epub 2020 Jan 21.
8
Long-term direct and indirect costs of ulcerative colitis in a privately-insured United States population.美国私人保险人群中溃疡性结肠炎的长期直接和间接成本。
Curr Med Res Opin. 2020 Aug;36(8):1285-1294. doi: 10.1080/03007995.2020.1771293. Epub 2020 Jun 9.
9
Cost Burden of Crohn's Disease and Ulcerative Colitis in the 10-Year Period Before Diagnosis-A Danish Register-Based Study From 2003-2015.诊断前 10 年克罗恩病和溃疡性结肠炎的经济负担:一项基于丹麦登记数据的 2003-2015 年研究。
Inflamm Bowel Dis. 2020 Aug 20;26(9):1377-1382. doi: 10.1093/ibd/izz265.
10
[Economic cost of treating the patient with asthma in Spain: the AsmaCost study].[西班牙哮喘患者的治疗经济成本:阿斯马成本研究]
Arch Bronconeumol. 2009 Oct;45(10):481-6. doi: 10.1016/j.arbres.2009.04.006. Epub 2009 Jun 13.

引用本文的文献

1
Work Productivity Impairment in Persons with Inflammatory Bowel Diseases: A Systematic Review and Meta-analysis.炎症性肠病患者的工作生产力受损:系统评价和荟萃分析。
J Crohns Colitis. 2024 Sep 3;18(9):1486-1504. doi: 10.1093/ecco-jcc/jjae057.
2
Epidemiological, Clinical, Patient-Reported and Economic Burden of Inflammatory Bowel Disease (Ulcerative colitis and Crohn's disease) in Spain: A Systematic Review.西班牙炎症性肠病(溃疡性结肠炎和克罗恩病)的流行病学、临床、患者报告和经济负担:系统评价。
Adv Ther. 2023 May;40(5):1975-2014. doi: 10.1007/s12325-023-02473-6. Epub 2023 Mar 16.
3
Feeding Difficulties Associated with IBD during the Working Day: Qualitative Study, Alicante Spain.
工作期间与 IBD 相关的喂养困难:定性研究,西班牙阿利坎特。
Int J Environ Res Public Health. 2022 Mar 17;19(6):3589. doi: 10.3390/ijerph19063589.
4
Systematic review: societal cost of illness of inflammatory bowel disease is increasing due to biologics and varies between continents.系统评价:生物制剂导致炎症性肠病的疾病社会成本增加,并因各大洲而异。
Aliment Pharmacol Ther. 2021 Aug;54(3):234-248. doi: 10.1111/apt.16445. Epub 2021 Jun 11.
5
Healthcare use, work loss and total costs in incident and prevalent Crohn's disease and ulcerative colitis: results from a nationwide study in Sweden.在瑞典进行的全国性研究:首发和现患克罗恩病和溃疡性结肠炎的医疗保健利用、工作损失和总费用。
Aliment Pharmacol Ther. 2020 Aug;52(4):655-668. doi: 10.1111/apt.15889. Epub 2020 Jul 3.
6
Indirect costs associated with ulcerative colitis: a systematic literature review of real-world data.与溃疡性结肠炎相关的间接成本:真实世界数据的系统文献回顾。
BMC Gastroenterol. 2019 Nov 9;19(1):179. doi: 10.1186/s12876-019-1095-9.
7
The Impact of Inflammatory Bowel Disease in Canada 2018: Direct Costs and Health Services Utilization.2018年炎症性肠病对加拿大的影响:直接成本与医疗服务利用情况
J Can Assoc Gastroenterol. 2019 Feb;2(Suppl 1):S17-S33. doi: 10.1093/jcag/gwy055. Epub 2018 Nov 2.